BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6234430)

  • 1. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
    Buchalter MS; Wannmacher CM; Wajner M
    J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sandhoff disease heterozygote detection: a component of population screening for Tay-Sachs disease carriers. I. Statistical methods.
    Cantor RM; Lim JS; Roy C; Kaback MM
    Am J Hum Genet; 1985 Sep; 37(5):912-21. PubMed ID: 4050790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
    Peleg L; Goldman B
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tay-Sachs disease heterozygote detection: use of a centrifugal analyser for automation of hexosaminidase assays with two different artificial substrates.
    Landels EC; Ellis IH; Bobrow M; Fensom AH
    J Med Genet; 1991 Feb; 28(2):101-9. PubMed ID: 1825851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
    Natowicz MR; Prence EM
    Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease.
    Prence EM; Natowicz MR; Zalewski I
    Clin Chem; 1993 Sep; 39(9):1811-4. PubMed ID: 8375052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
    Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
    Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two abnormalities of hexosaminidase A in clinically normal individuals.
    Grebner EE; Mansfield DA; Raghavan SS; Kolodny EH; d'Azzo A; Neufeld EF; Jackson LG
    Am J Hum Genet; 1986 Apr; 38(4):505-14. PubMed ID: 2939713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
    Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
    Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency.
    Argov Z; Navon R
    Ann Neurol; 1984 Jul; 16(1):14-20. PubMed ID: 6235771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases.
    Willner JP; Grabowski GA; Gordon RE; Bender AN; Desnick RJ
    Neurology; 1981 Jul; 31(7):787-98. PubMed ID: 6454083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygosity for Tay-Sachs and Sandhoff diseases in non-Jewish Americans with ancestry from Ireland, Great Britain, or Italy.
    Branda KJ; Tomczak J; Natowicz MR
    Genet Test; 2004; 8(2):174-80. PubMed ID: 15345116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal activation of hexosaminidase A in a genetic compound with Tay-Sachs disease.
    Ben-Yoseph Y; Baylerian MS; Momoi T; Nadler HL
    J Inherit Metab Dis; 1983; 6(3):95-100. PubMed ID: 6230486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
    Hechtman P; Khoo K; Isaacs C
    Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
    Strasberg PM; Clarke JT
    Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Tay-Sachs by hexosaminidase analysis of urine and tear samples.
    Saifer A; Amoroso J; Perle G
    Adv Exp Med Biol; 1976; 68():339-66. PubMed ID: 7107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segregation of Tay-Sachs and Sandhoff alleles in a non-Jewish family.
    Lane AB; Young E; Jenkins T
    Am J Hum Genet; 1980 Nov; 32(6):920-6. PubMed ID: 7446530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.
    Triggs-Raine B; Richard M; Wasel N; Prence EM; Natowicz MR
    Am J Hum Genet; 1995 Apr; 56(4):870-9. PubMed ID: 7717398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain.
    van Bael M; Natowicz MR; Tomczak J; Grebner EE; Prence EM
    J Med Genet; 1996 Oct; 33(10):829-32. PubMed ID: 8933335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
    Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
    Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.